NATHAN CROWDER: Open Payments
NPI 1417329459 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,907 in 63 payments from 12 companies in 2025. Trend: 2023 $812 · 2024 $1,299 · 2025 $1,907
Food & beverage: $1,808Education: $98
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 19 | $673 |
| GENZYME CORPORATION | 6 | $278 |
| GlaxoSmithKline, LLC. | 10 | $197 |
| Medtronic, Inc. | 7 | $196 |
| Integra LifeSciences Corporation | 8 | $165 |
| AstraZeneca Pharmaceuticals LP | 1 | $124 |
| Olympus America Inc. | 4 | $83 |
| Smith+Nephew, Inc. | 2 | $70 |
| Optinose US, Inc. | 3 | $61 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
Products named: DUPIXENT, NUCALA, PROPEL, ACCLARENT AERA, TEZSPIRE, Xhance, OLYMPUS, Sinuva.
Industry payments across TX — which companies pay providers there.
